Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy

Saïd M Sebti1

  • 1Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute, Department of Interdisciplinary Oncology, University of South Florida College of Medicine, Tampa, Florida 33612, USA. sebti@moffitt.usf.edu

Cancer Cell
|April 20, 2005
PubMed

Insights

Protein farnesylation is vital for early development and cancer progression, but not adult health. Farnesyltransferase inhibitors (FTIs) show promise, targeting Rab geranylgeranyltransferase in cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein farnesylation is a critical lipid modification for oncogenic proteins like Ras.
  • The precise role of protein farnesylation in normal physiology and cancer remains unclear.
  • Farnesyltransferase inhibitors (FTIs) are under clinical investigation for cancer treatment.

Purpose of the Study:

  • To elucidate the role of protein farnesylation in normal physiological processes.
  • To investigate the involvement of protein farnesylation in tumorigenesis.
  • To identify novel targets for farnesyltransferase inhibitors in cancer therapy.

Main Methods:

  • Analysis of protein farnesylation's essentiality in embryogenesis and adult homeostasis.
  • Assessment of protein farnesylation's role in tumor initiation versus progression.
  • Identification of molecular targets for farnesyltransferase inhibitors.

Main Results:

  • Protein farnesylation is essential for early embryogenesis but dispensable for adult homeostasis.
  • Farnesylation is critical for cancer progression, not initiation.
  • Rab geranylgeranyltransferase is identified as a target for certain FTIs.

Conclusions:

  • Protein farnesylation plays distinct roles in development, homeostasis, and cancer.
  • FTIs targeting Rab geranylgeranyltransferase offer potential therapeutic strategies.
  • Understanding farnesylation mechanisms is key for advancing cancer therapy.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...